期刊文献+

联合降压治疗对高血压病患者外周血中血管活性物质的影响及意义 被引量:2

Significance and effect of combination antihypertensive therapy on vasoactive substances in peripheral blood in patients with hypertension
原文传递
导出
摘要 目的观察非洛地平联合坎地沙坦对高血压患者血浆尾加压素Ⅱ(UⅡ)、脂联素(ADI)和血管紧张素Ⅱ(Ang Ⅱ)的影响。方法将88例入选患者作为治疗组,24例健康人群作为对照组,治疗组给予非洛地平及坎地沙坦治疗,测定治疗组患者药物治疗前后的外周血和对照组外周血中UⅡ、ADI、AngⅡ变化。结果治疗组UⅡ和AngⅡ水平高于对照组(t=3.961和t=2.816,均P<0.01),ADI低于对照组(t=16.243,P<0.01)。治疗组治疗后较治疗前血压下降明显(P<0.01);UⅡ降低(t=2.024,P<0.05),ADI升高(t=5.589,P<0.01)。结论非洛地平联合坎地沙坦可降低高血压患者外周血UⅡ水平,升高ADI、Ang Ⅱ水平。降低血压后,减轻了对ADI的抑制,减少了对UⅡ释放的诱导,提示联合降压治疗对高血压患者具有血管保护作用。 [Objective]To observe the effect of candesartan combined with felodipine on plasma urotensin Ⅱ( UⅡ),adiponectin( ADI) and angiotensin( Ang II) in patients with hypertension.[Methods]88 patients with hypertension were considered as the treatment group,and 24 healthy people were enrolled in the control group. The treatment group was given the candesartan and felodipine. The levels of UⅡ,ADI and AngⅡ in peripheral blood of two groups before and after treatment were measured.[Results]The levels of UⅡ and AngⅡ in the treatment group were higher than those in the control group( t = 3. 961 and t = 2. 816,both P 0. 01),while ADI level in the treatment group was lower than that in the control group( t = 16. 243,P 0. 01). In the treatment group,the blood pressure after treatment significantly decreased as compared with before treatment( P 0. 01),UⅡ level reduced( t = 2. 024,P 0. 05),and ADI level increased( t = 5. 589,P 0. 01).[Conclusion]Candesartan combined with felodipine can reduce UⅡ level,and increase levels of ADI and Ang II in peripheral blood in patients with hypertension. When blood pressure has been controlled,the inhibition of ADI is alleviated,and the induction of U Ⅱ release is reduced,and it is suggested that combination antihypertensive therapy has the protective effect on blood vessel of patients with hypertension.
出处 《职业与健康》 CAS 2014年第14期2043-2045,共3页 Occupation and Health
基金 湖北省科技厅科研项目(项目编号:2011CDC049) 湖北省教育厅科研项目(项目编号:B20102104) 十堰市重点项目(项目编号:072S)
关键词 非洛地平 坎地沙坦 脂联素 尾加压素Ⅱ 血管紧张素Ⅱ Felodipine Candesartan Adiponectin(ADI) Urotensin Ⅱ(UⅡ) Angiotensin(Ang Ⅱ)
  • 相关文献

参考文献12

  • 1刘力生.中国高血压防治指南2010[J].中华高血压杂志,2011,19(8):701-708. 被引量:6936
  • 2Ames RS, Saran HM, Chambers JK, et al, Human urotensin-II is a po- tent vasoconstrictor and agonist for the orphan receptor GPR14 [ J]. Na- ture, 1999, 401 : 282 -286.
  • 3Le MJC, Olson KR, Conklin D, et al, Cardiovascular actions of trout urotensin II in the conscious trout, Oncorhynchus mykiss [ J ]. Am J Physiol, 1996, 271 (5 Pt 2) : R1335 - 1343.
  • 4Onat AM, Pehlivan Y, Turkbeyler IH, et al. Urotensin inhibition with palosuran could be a promising alternative in pulmonary arterial hyper- tension[J]. Inflammation, 2013, 36:405-412.
  • 5Van de Voorde J, Pauwels B, Boydens C, et al. Adipocytokines in rela- tion to cardiovascular disease. LID - S0026 - 0495 ( 13 ) 00184 - 4 [ pii ] LID - 10. 1016/j. metabol. 2013.06. 004 [ doi ] [ J ]. Metabolism, 2013 .
  • 6Hattori Y, Akimoto K, Gross SS, et al. Angiotensin-II-induced oxida- tive stress elicits hypoadiponectinaemia in rats [ J ]. Diabetologia, 2005, 48 : 1066 - 1074.
  • 7Zouein FA, Zgheib C, Hamza S, et al. Role of STAT3 in angiotensin II- induced hypertension and cardiac remodeling revealed by mice lacking STAT3 serine 727 phosphorylatian [ J]. Hypertens Res, 2013,36: 496 - 503.
  • 8Wallace AE, Cartwright JE, Begum R, et al. Trophoblast-induced changes in C-x-C motif ehemokine 10 expression contribute to vascular smooth muscle cell dedifferentiation during spiral artery remodeling[J]. Arterioseler Thromb Vase Biol, 2013, 33 : e93 - el01.
  • 9Shimoda LA, Laurie SS. Vascular remodeling in pulmonary hypertension[J]. J Mol Med (Bed), 2013, 91:297 -309.
  • 10丁绍祥.原发性高血压发病机制及治疗探讨[J].航空航天医学杂志,2009,21(10):30-32. 被引量:22

二级参考文献55

共引文献7022

同被引文献12

引证文献2

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部